Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager

Moberg Pharma AB (publ)

STO:MOB

Watchlist

Dividends

Price: 18.26 SEK -4.85% Market Closed

Market Cap: 852.6m SEK

Have any thoughts about
Moberg Pharma AB (publ)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 18.26 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MOB Alert

Moberg Pharma AB (publ)

18.26

-0.93 (-4.85%)

52 Week Range	9.645 38.92
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Moberg Pharma AB (publ)

What unique competitive advantages
does Moberg Pharma AB (publ) hold over its rivals?

What risks and challenges
does Moberg Pharma AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Moberg Pharma AB (publ).

What unique competitive advantages
does Moberg Pharma AB (publ) hold over its rivals?

What risks and challenges
does Moberg Pharma AB (publ) face in the near future?

Has there been any significant insider trading activity
in Moberg Pharma AB (publ) recently?

Summarize the latest earnings call
of Moberg Pharma AB (publ).

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Moberg Pharma AB (publ).

Provide P/S
for Moberg Pharma AB (publ).

Provide P/E
for Moberg Pharma AB (publ).

Provide P/OCF
for Moberg Pharma AB (publ).

Provide P/FCFE
for Moberg Pharma AB (publ).

Provide P/B
for Moberg Pharma AB (publ).

Provide EV/S
for Moberg Pharma AB (publ).

Provide EV/GP
for Moberg Pharma AB (publ).

Provide EV/EBITDA
for Moberg Pharma AB (publ).

Provide EV/EBIT
for Moberg Pharma AB (publ).

Provide EV/OCF
for Moberg Pharma AB (publ).

Provide EV/FCFF
for Moberg Pharma AB (publ).

Provide EV/IC
for Moberg Pharma AB (publ).

Show me price targets
for Moberg Pharma AB (publ) made by professional analysts.

What are the Revenue projections
for Moberg Pharma AB (publ)?

How accurate were the past Revenue estimates
for Moberg Pharma AB (publ)?

What are the Net Income projections
for Moberg Pharma AB (publ)?

How accurate were the past Net Income estimates
for Moberg Pharma AB (publ)?

What are the EPS projections
for Moberg Pharma AB (publ)?

How accurate were the past EPS estimates
for Moberg Pharma AB (publ)?

What are the EBIT projections
for Moberg Pharma AB (publ)?

How accurate were the past EBIT estimates
for Moberg Pharma AB (publ)?

Compare the revenue forecasts
for Moberg Pharma AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Moberg Pharma AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Moberg Pharma AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Moberg Pharma AB (publ) compared to its peers.

Compare the P/E ratios
of Moberg Pharma AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing Moberg Pharma AB (publ) with its peers.

Analyze the financial leverage
of Moberg Pharma AB (publ) compared to its main competitors.

Show all profitability ratios
for Moberg Pharma AB (publ).

Provide ROE
for Moberg Pharma AB (publ).

Provide ROA
for Moberg Pharma AB (publ).

Provide ROIC
for Moberg Pharma AB (publ).

Provide ROCE
for Moberg Pharma AB (publ).

Provide Gross Margin
for Moberg Pharma AB (publ).

Provide Operating Margin
for Moberg Pharma AB (publ).

Provide Net Margin
for Moberg Pharma AB (publ).

Provide FCF Margin
for Moberg Pharma AB (publ).

Show all solvency ratios
for Moberg Pharma AB (publ).

Provide D/E Ratio
for Moberg Pharma AB (publ).

Provide D/A Ratio
for Moberg Pharma AB (publ).

Provide Interest Coverage Ratio
for Moberg Pharma AB (publ).

Provide Altman Z-Score Ratio
for Moberg Pharma AB (publ).

Provide Quick Ratio
for Moberg Pharma AB (publ).

Provide Current Ratio
for Moberg Pharma AB (publ).

Provide Cash Ratio
for Moberg Pharma AB (publ).

What is the historical Revenue growth
over the last 5 years for Moberg Pharma AB (publ)?

What is the historical Net Income growth
over the last 5 years for Moberg Pharma AB (publ)?

What is the current Free Cash Flow
of Moberg Pharma AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Moberg Pharma AB (publ).

Financials Section:

Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Balance Sheet Decomposition
Moberg Pharma AB (publ)

Current Assets	347.9m
Cash & Short-Term Investments	326m
Receivables	16.9m
Other Current Assets	5m
Non-Current Assets	611.7m
PP&E	4.3m
Intangibles	574.8m
Other Non-Current Assets	32.6m

Current Liabilities	27.8m
Other Current Liabilities	27.8m
Non-Current Liabilities	2.7m
Long-Term Debt	2.7m

Balance Sheet
Moberg Pharma AB (publ)

Rotate your device to view
Balance Sheet

Currency: SEK

	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	19	103	126	61
Cash Equivalents	19	103	126	61
Total Receivables	2	1	1	1
Accounts Receivables	0	0	0	0
Other Receivables	2	1	1	1
Inventory	0	0	0	7
Other Current Assets	145	1	1	1
Total Current Assets	167	105	128	69
PP&E Net	7	5	6	5
PP&E Gross	7	5	6	5
Accumulated Depreciation	2	2	2	2
Intangible Assets	296	327	408	532
Other Long-Term Assets	11	15	23	28
Total Assets	481 N/A	451 -6%	564 +25%	635 +12%
Liabilities
Accounts Payable	3	5	17	7
Accrued Liabilities	27	7	7	9
Short-Term Debt	0	0	0	0
Current Portion of Long-Term Debt	3	3	2	1
Other Current Liabilities	48	1	1	3
Total Current Liabilities	80	16	27	21
Long-Term Debt	5	1	4	3
Minority Interest	8	0	0	0
Other Liabilities	0	0	0	0
Total Liabilities	93 N/A	17 -82%	31 +83%	24 -22%
Equity
Common Stock	2	4	10	28
Retained Earnings	307	302	317	339
Additional Paid In Capital	693	731	841	921
Other Equity	0	0	0	0
Total Equity	388 N/A	434 +12%	534 +23%	611 +14%
Total Liabilities & Equity	481 N/A	451 -6%	564 +25%	635 +12%
Shares Outstanding
Common Shares Outstanding	7	7	15	28

Switch to:

Income Statement Balance Sheet Cash Flow Statement

Switch to:

Income Statement Balance Sheet Cash Flow Statement

Moberg Pharma AB (publ)
STO:MOB

Balance Sheet

Balance Sheet Decomposition
Moberg Pharma AB (publ)

Balance Sheet
Moberg Pharma AB (publ)

See Also

Company

Help

Tools

Stocks

Moberg Pharma AB (publ) STO:MOB

Balance Sheet

Balance Sheet Decomposition Moberg Pharma AB (publ)

Balance Sheet Moberg Pharma AB (publ)

See Also

Company

Help

Tools

Stocks

Moberg Pharma AB (publ)
STO:MOB

Balance Sheet Decomposition
Moberg Pharma AB (publ)

Balance Sheet
Moberg Pharma AB (publ)